Saliva for diagnosis of SARS‐CoV‐2: First report from India
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
There are very few studies in search of an alternate and convenient diagnostic tool which can substitute nasopharyngeal swab (NPS) specimen for detection of SARS‐CoV‐2. In the study we analyzed, the comparison and agreement between the feasibility of using the saliva in comparison to NPS for diagnosis of SARS‐CoV‐2. A total number of 74 patients were enrolled for this study. We analyzed and compared the NPS and saliva specimen collected within 48 h after the symptom onset. We carried out real‐time quantitative polymerase chain reaction, gene sequencing for the detection and determination SARS‐CoV‐2 specific genes. Phylogenetic tree was constructed to establish the isolation of viral RNA from saliva. We used the Bland–Altman model to identify the agreement between two specimens. This study showed a lower cycle threshold ( C T ) mean value for the detection of SARS‐CoV‐2 ORF1 gene (mean, 27.07; 95% confidence interval [CI], 25.62 to 28.52) in saliva methods than that of NPS (mean 28.24; 95% CI, 26.62 to 29.85) specimen although the difference is statistically nonsignificant ( p > .05). Bland–Altman analysis produced relatively smaller bias and high agreement between these two clinical specimens. Phylogenetic analysis with the RdRp and S gene confirmed the presence of SARS‐CoV‐2 in the saliva samples. Saliva represented a promising tool in COVID‐19 diagnosis and the collection method would reduce the exposure risk of frontline health workers which is one of the major concerns in primary healthcare settings.
Article activity feed
-
SciScore for 10.1101/2020.09.11.20192591: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: The study was approved by Institutional Ethics Committee and written consent was obtained from the patients.
Consent: The study was approved by Institutional Ethics Committee and written consent was obtained from the patients.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Gene sequence and phylogenetic tree analysis: The forward and reverse sequences of RdRp and S genes isolated from saliva were edited manually in the electro-pherograms by SeqScape v2.5 software (Applied Biosystem, USA). SeqScapesuggested: (SeqScape Software, RRID:SC…SciScore for 10.1101/2020.09.11.20192591: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: The study was approved by Institutional Ethics Committee and written consent was obtained from the patients.
Consent: The study was approved by Institutional Ethics Committee and written consent was obtained from the patients.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Gene sequence and phylogenetic tree analysis: The forward and reverse sequences of RdRp and S genes isolated from saliva were edited manually in the electro-pherograms by SeqScape v2.5 software (Applied Biosystem, USA). SeqScapesuggested: (SeqScape Software, RRID:SCR_001604)Statistical analysis: Descriptive statistical analyses were performed using GraphPad Prism 7.04 for Windows (GraphPad Software, La Jolla, USA) GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-